TipRanks

Thomas Desrosier Insider Profile

11 Followers
Thomas Desrosier, EVP & CLO at Seres Therapeutics, holds 8.12K shares in Seres Therapeutics (Ticker: MCRB), holds 0.00 shares in Ariad (Ticker: ~ARIA), holds 0.00 shares in Cubist Pharma (Ticker: CBST).
tipranks
Thomas Desrosier

Thomas Desrosier
Seres Therapeutics (MCRB)
EVP & CLO

Ranked #35,648 out of 109,106 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+43.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$32K
100.00%
A breakdown of Thomas Desrosier's holdings

Insider Roles

Seres Therapeutics
(MCRB)
EVP & CLO
Roles that Thomas Desrosier holds in companies

Most Profitable Insider Trade

Stock:
Seres Therapeutics
(MCRB)
Rating:Informative Sell
Date:Jan 29, 2019 - Jan 29, 2020
Return:+45.30%
The most profitable trade made by Thomas Desrosier

Thomas Desrosier's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Seres Therapeutics
Aug 18, 2026
EVP & CLO
Uninformative Buy
740.02
$32.47K
~ARIA
Ariad
$0.00
CBST
Cubist Pharma
Jan 21, 2015
Uninformative Sell
861.49K
List of latest transactions for each holding click on a transaction to see Thomas Desrosier's performance on stock

Thomas Desrosier insider profile FAQ

What is the percentage of profitable transactions made by Thomas Desrosier?
The percentage of profitable transactions made by Thomas Desrosier is 100%.
    What is the average return per transaction made by Thomas Desrosier?
    The average return per transaction made by Thomas Desrosier is 43.20%.
      What stocks does Thomas Desrosier hold?
      Thomas Desrosier holds: MCRB, ~ARIA, CBST stocks.
        What was Thomas Desrosier’s latest transaction?
        Thomas Desrosier latest transaction was an Uninformative Buy of $740.02.
          What was Thomas Desrosier's most profitable transaction?
          Thomas Desrosier’s most profitable transaction was an Informative Sell of MCRB stock on January 29, 2019. The return on the trade was 45.30%.
            What is Thomas Desrosier's role in Seres Therapeutics?
            Thomas Desrosier's role in Seres Therapeutics is EVP & CLO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.